NRP1 and benign granular cell tumor: In myoblastoma (MB), overexpression of NRP1 plays a key role in the survival of CSCs, inhibiting the NRP1 via a peptidomimetic specifically targeting the protein by losing their stemness characteristics, thereby decreasing the invasiveness capacity of MB CSCs.